Ivermectin for Severe COVID-19 Management

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
In this multicenter study; it was aimed to investigate the effectiveness and safety of ivermectin use in the treatment of patients with severe COVID-19 pneumonia that have no mutations which alter ivermectin metabolism and cause side effects.
Epistemonikos ID: 2200bf13169b56d5bb1cb4d56b17a092bd4dda6a
First added on: Nov 28, 2020